C

Check-Cap Ltd
D

CHEK

0.82000
USD
-0.09
(-9.99%)
Market Closed
Volume
94
EPS
-3
Div Yield
-
P/E
-0
Market Cap
4,796,357
Related Instruments
    C
    CORT
    -2.950
    (-5.39%)
    51.830 USD
    G
    GTHX
    0.01000
    (0.14%)
    7.16000 USD
    M
    MTEM
    -0.14200
    (-23.67%)
    0.45800 USD
    N
    NAOV
    -0.01870
    (-2.84%)
    0.63950 USD
    N
    NOVN
    0.02000
    (1.82%)
    1.08000 USD
    R
    RETO
    -0.05000
    (-4.85%)
    0.98000 USD
    More
News

Title: Check/Cap Ltd

Sector: Healthcare
Industry: Diagnostics & Research
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.